Stockreport

Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update

Synlogic, Inc.  (SYBX) 
Last synlogic, inc. earnings: 3/12 04:19 pm Check Earnings Report
PDF Decision to end trial follows internal review of initial data indicating study unlikely to meet primary endpoint Data review found treatment to be safe and well-tolerat [Read more]